期刊文献+

经典型霍奇金淋巴瘤组织中脆性三联组氨酸蛋白表达的意义

Expression of fragile histidine triad (FHIT) protein and its significance in diagnosing classical Hodgkin lymphoma
原文传递
导出
摘要 目的探讨脆性三联组氨酸(FHIT)蛋白在经典型霍奇金淋巴瘤(CHL)组织中的表达及其意义。方法对33例确诊的CHL组织采用免疫组织化学EnVision法检测其抑癌基因蛋白FHIT、造血系统肿瘤干细胞标记CD133/AC133、CD34、B细胞标记CD20、T细胞标记CD3和癌基因蛋白c-erbB-2表达状况。结果90·9%(30/33)CHL组织中FHIT蛋白表达阳性,表达定位于肿瘤细胞的胞质、胞核和胞膜;对照组正常B、T淋巴细胞和B、T细胞淋巴瘤FHIT蛋白表达均为阴性;单核细胞、组织细胞以及树突状组织细胞均表达阳性。CD133/AC133、CD34、CD3、c-erbB-2表达均为阴性,2例CD20阳性。结论FHIT蛋白检测可作为诊断CHL的一个辅助指标。 Objective To study the expression of FHIT protein and its potential application in diagnosing classic Hodgkin lymphoma. Methods Immunohistocbemical study using EnVision method for FHIT tumor suppressor protein, hematopoietic stem cell markers CD133/AC133 and CD34, B-cell marker CD20, T-cell marker CD3 and oncoprotein c-erbB2 was performed on 33 cases of classic Hodgkin lymphoma, Results Thirty-three of the Hodgkin lymphoma cases (90. 9% ) expressed FH1T protein. The antigen was mainly located in the cytoplasm, nucleus and membrane of classic Beed-Stemberg and Reed- Steinberg-like cells. Normal B and T lymphocytes, as well as their malignant counterparts, were negative for FHIT protein; whereas monocytes, histiocytes and dendritic cells were positive. All the cases studied were negative for CD133/AC133, CD34, CD3 and c-erbB-2. Two of the 33 cases showed positive staining for CD20 in some of the Reed-Steinberg cells. Conclusion The expression of FHIT protein can be used as a useful adjunct in diagnosing classic Hodgkin lymphoma.
出处 《中华病理学杂志》 CAS CSCD 北大核心 2006年第5期289-291,共3页 Chinese Journal of Pathology
关键词 淋巴瘤 霍奇金 FHIT蛋白 Lymphoma, Hodgkin FHrr protein
  • 相关文献

参考文献2

二级参考文献49

  • 1易平勇,杨光华,谭永淑,李甘地.大肠腺癌的核形态定量分析及其在临床病理上的意义[J].中华病理学杂志,1994,23(3):141-143. 被引量:7
  • 2Croce CM, Sozzi G, Huebner K. Role of FHIT in human cancer. J Clin Oncol 1999; 17:1618-1624.
  • 3Huebner K, Druck T, Siprashvili Z, Croce CM, Kovatich A,McCue PA. The role of deletions at the FRA3B/FHIT locus in carcinogenesis. Recent Results Cancer Res 1998; 154:200-215.
  • 4Sorio C, Baron A, Orlandini S, Zamboni G, Pederzoli P, Huebner K, Scarpa A. The FHIT gene is expressed in pancreatic ductular cells and is altered in pancreatic cancers. Cancer Res 1999; 59:1308-1314.
  • 5Hadaczek P, Siprashvili Z, Markiewski M, Domagala W, Druck T, McCue PA, Pekarsky Y, Ohta M, Huebner K, Lubinski J. Absence or reduction of Fhit expression in most clear cell renal carcinomas. Cancer Res 1998; 58:2946-2951.
  • 6Werner NS, Siprashvili Z, Fong LY, Marquitan G, Schroder JK,Bardenheuer W, Seeber S, Huebner K, Schutte J, Opalka B. Differential susceptibility of renal carcinoma cell lines to tumor suppression by exogenous Fhit expression. Cancer Res 2000; 60:2780-2785.
  • 7Greenspan DL, Connolly DC, Wu R, Lei RY, Vogelstein JT, Kim YT, Mok JE, Munoz N, Bosch FX, Shah K, Cho KR. Loss of FHIT expression in cervical carcinoma cell lines and primary tumors.Cancer Res 1997; 57:4692-4698.
  • 8Yoshino K, Enomoto T, Nakamura T, Nakashima R, Wada H,Saitoh J, Noda K, Murata Y. Aberrant FHIT transcripts in squamous cell carcinoma of the uterine cervix. Int J Cancer 1998; 76:176-181.
  • 9Druck T, Berk L, Huebner K. FHITness and cancer. Oncol Res 1998; 10:341-345.
  • 10Fong KM, Biesterveld EJ, Virmani A, Wistuba I, Sekido Y, Bader SA, Ahmadian M, Ong ST, Rassool FV, Zimmerman PV, Giaccone G, Gazdar A.F, Minna JD. FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations. Cancer Res 1997; 57:2256-2267.

共引文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部